JOURNAL OF NEW DISCOVERY IN MICROBIOLOGY
Integrity Research Journals

ISSN: 3122-0207
Model: Open Access/Peer Reviewed
DOI: 10.31248/JNDM
Start Year: 2020
Email: jndim@integrityresjournals.org


Concept of tinea cruris

https://doi.org/10.31248/JNDM2023.009   |   Article Number: F3BFA0F93   |   Vol.2 (1) - February 2024

Received Date: 08 September 2023   |   Accepted Date: 20 November 2023  |   Published Date: 28 February 2024

Authors:  Ahmad Aliyu* and Mabekoje Oladele Olatunbosun

Keywords: Dermatophytes, jock itch, perianal, pruritic, superficial, therapy, Trichophyton rubrum.

Tinea cruris (Jock Itch) is a pruritic superficial dermatophytic infection, particularly involving the perianal and perineal skin, genitalia and pubic region. Associated morbidities of jock itch include secondary bacterial infection, contact dermatitis from topical medications and lichenification. Risk factors include hyperhidrosis, tight-fitting wear, diabetes mellitus, and obesity, which suppress the immune response to the infection. This study reviewed the current and common dermatophyte species of Tinea cruris including demography, clinical presentation, diagnosis, differential diagnosis and the treatment of the infection. A Google search was conducted using the key terms “Tinea cruris” “Jock Itch” “Dermatophytosis” and “Tinea infections”. The search strategy includes literature reviews, meta-analyses, clinical and observational studies. The result shows that the most commonly affected age group in females was between 31 – 40 years (32.7%), while affected males were between 21 – 30 years (40.0%). The most common clinical presentation was tinea cruris in females (27.3%) and males (25.3%) when compared to dual site tinea cruris and tinea corporis in both genders. The most common dermatophytes of the infection include Trichophyton rubrum, Trichophyton mentagrophytes, Microsporum gypseum and Microsporum audouinii. Terbinafine, itraconazole and luliconazole 1% are more effective and require a short duration of treatment against the infection when compared to other antifungal agents. Darier disease, psoriasis vulgaris, erythrasma, seborrheic dermatitis, cutaneous candidiasis, intertrigo, pemphigus vegetans, contact dermatitis, langerhans cell histiocytosis, lichen simplex chronicus, majocchi granuloma and tinea versicolor may resemble tinea cruris. There has been a significant rise in the incidence of chronic dermatophyte infections of the skin due to the paucity of research on superficial fungal infections and the poor efficacy of the available antifungal agents. More studies are urgently needed on pathogenesis, diagnosis and effective therapy against tinea cruris.

Abanmi, A., Bakheshwain, S., El Khizzi, N., Zouman, A. R., Hantirah, S., Al Harthi, F., Al Jamal, M., Rizvi, S. S., Ahmad, M., & Tariq, M. (2008). Characteristics of superficial fungal infections in the Riyadh region of Saudi Arabia. International Journal of Dermatology, 47(3), 229-235.
Crossref
 
Alston, S. J., Cohen, B. A., & Braun, M. (2003). Persistent and recurrent tinea corporis in children treated with combination antifungal/corticosteroid agents. Pediatrics, 111(1), 201-203.
Crossref
 
Andrews, M. D., & Burns, M. (2008). Common tinea infections in children. American Family Physician, 77(10), 1415-1420.
 
Arshah, T. M., Muftah al-bakosh, A., Ali, M. M., Ramadan, H. A., Alshawish, S. S., Algondy, M. A., Alrtail, A. & Rzeg, M. (2015). Epidemiology of superficial fungal skin infections in patients attending Zliten teaching hospital. Journal of Basic Sciences, 27, 83-93.
 
Attapattu, M. C. (1998). The changing patterns of dermatomycoses in Sri Lanka. Sri Lanka Journal of Dermatology, 3, 3-8.
 
Basavarajappa, S. M., Madhusudhan, K. S., Rudrappa, M. R., & Reddy, K. S. (2022). Evaluation of antifungal susceptibility pattern of dermatophytes isolated in a tertiary care hospital. National Journal of Physiology, Pharmacy and Pharmacology, 12(10), 1565-1571.
Crossref
 
Bell Syer, S. E, Khan, S. M., & Torgerson, D. J. (2012). Oral treatments for fungal infections of the skin of the foot. Cochrane Database Systematic Reviews, 10, CD003584.
Crossref
 
Bourlond, A., Lachapelle, J. M., Aussems, J., Boyden, B., Campaert, H., Conincx, S., Decroix, J., Geeraerts, C., Ghekiere, L., Porters, J., & Willocx, D. (1989). Double‐blind comparison of itraconazole with griseofulvin in the treatment of tinea corporis and tinea cruris. International Journal of Dermatology, 28(6), 410-412.
Crossref
 
Chaudhary, J. K., & Kumar, A. A. (2016). Clinico-Mycological profile of dermatophytosis at a tertiary care hospital in Bihar. International Journal of Current Microbiology and Applied Science, 5(2),181-189.
Crossref
 
Cole, G. W., & Stricklin, G. (1989). A comparison of a new oral antifungal, terbinafine, with griseofulvin as therapy for tinea corporis. Archives of Dermatology, 125(11), 1537-1539.
Crossref
 
Dabas, Y., Xess, I., Singh, G., Pandey, M., & Meena, S. (2017). Molecular identification and antifungal susceptibility patterns of clinical dermatophytes following CLSI and EUCAST guidelines. Journal of Fungi, 3(2), 17.
Crossref
 
Darade, R. B., Zambare, K. K., Jaiswal, N. R., & Kaware, A. A. (2019). An overview on pharmacotherapy of Jock itch (Tinea cruris). World Journal of Pharmaceutical Research, 9(1), 851-856.
 
Drake, L. A., Dinehart, S. M., Farmer, E. R., Goltz, R. W., Graham, G. F., Hordinsky, M. K., Lewis, C. W., Pariser, D. M., Skouge, J. W., Webster, S. B., & Scher, R. K. (1996). Guidelines of care for superficial mycotic infectionsof the skin: Tinea corporis, tinea cruris, tinea faciei, tinea manuum, and tinea pedis. Journal of the American Academy of Dermatology, 34(2), 282-286.
Crossref
 
El‐Gohary, M., van Zuuren, E. J., Fedorowicz, Z., Burgess, H., Doney, L., Stuart, B., Moore, M. & Little, P. (2014). Topical antifungal treatments for tineacruris and tineacorporis. Cochrane Database of Systemic Reviews, 8, CD009992.
Crossref
 
Faergemann, J., Mörk, N. J., Haglund, A., & Ödegàrd, T. (1997). A multicentre (double‐blind) comparative study to assess the safety and efficacy of fluconazole and griseofulvin in the treatment of tinea corporis and tinea cruris. British Journal of Dermatology, 136(4), 575-577.
Crossref
 
Gupta, A. K., & Kohli, Y. (2003). In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. British Journal of Dermatology, 149(2), 296-305.
Crossref
 
Gupta, A. K., Chaudhry, M., & Elewski, B. (2003). Tinea corporis, tinea cruris, tinea nigra, and piedra. Dermatologic clinics, 21(3), 395-400.
Crossref
 
Gupta, B. K., Kumar, S., Kumar, R. A., & Khurana, S. (1993). Mycological aspects of dermatomycoses in Ludhiana. Indian Journal of Pathology and Microbiology, 36(3), 233-237.
 
Haedersdal, M., & Svejgaard, E. L. (2003). Systematic treatment of tinea pedis--evidence for treatment? A result of a Cochrane review. Ugeskrift for Laeger, 165(14), 1436-1438.
 
Havlickova, B., & Friedrich, M. (2008). The advantages of topical combination therapy in the treatment of inflammatory dermatomycoses. Mycoses, 51, 16-26.
Crossref
 
Havlickova, B., Czaika, V. A., & Friedrich, M. (2008). Epidemiological trends in skin mycoses worldwide. Mycoses, 51, 2-15.
Crossref
 
Hui, D., Xue‐cheng, S., & Ai‐e, X. (2013). Evaluation of reflectance confocal microscopy in dermatophytosis. Mycoses, 56(2), 130-133.
Crossref
 
Jachiet, M., Lanternier, F., Rybojad, M., Bagot, M., Ibrahim, L., Casanova, J. L., Puel, A., & Bouaziz, J. D. (2015). Posaconazole treatment of extensive skin and nail dermatophytosis due to autosomal recessive deficiency of CARD9. JAMA Dermatology, 151(2), 192-194.
Crossref
 
Kansra, S., Devi, P., Sidhu, S., & Malhotra, A. (2016). Prevalence of dermatophytosis and their antifungal susceptibility in a tertiary care hospital of North India. International Journal of Science and Research, 5(3), 450-453.
 
Kaur, R. (2017). Clinico-mycological pattern of hair and skin infection in New Delhi. Journal of Intensive and Critical Care, 3(2).
Crossref
 
Khanna, D., & Bharti, S. (2014). Luliconazole for the treatment of fungal infections: an evidence-based review. Core evidence, 9, 113-124.
Crossref
 
Konda, C., Surekha, J. K., Jahnavi, I., Madhuri, D. S., & Nagamani, K. (2017). Isolation and identification of dermatophytes in a tertiary care hospital. International Journal of Current Microbiology and Applied Sciences, 6, 4088-101.
Crossref
 
Kumar, M., Swami, T., Pannu, S., Datt, S., & Kumar, R. (2018). Study of clinico-mycologic profile and antifungal susceptibility pattern of dermatophytic infection in the North-Western Zone of Rajasthan, India. International Journal of Current Microbiology and Apply Sciences, 7, 762-65.
Crossref
 
Kurade, S. M., Amladi, S. A., & Miskeen, A. K. (2006). Skin scraping and a potassium hydroxide mount. Indian Journal of Dermatology, Venereology and Leprology, 72(3), 238 41
Crossref
 
Lee, W. J., Kim, S. L., Jang, Y. H., Lee, S. J., Bang, Y. J., & Jun, J. B. (2015). Increasing prevalence of Trichophyton rubrum identified through an analysis of 115,846 cases over the last 37 years. Journal of Korean Medical Science, 30(5), 639-643.
Crossref
 
Lesher Jr, J. L. (1999). Oral therapy of common superficial fungal infections of the skin. Journal of the American Academy of Dermatology, 40(6), S31-S34.
Crossref
 
Ma, X.N., Zhang, H., Han, X.H., et al. (2016). Clinical analysis of 1422 cases of superficial mycoses in Yan'an Area. The Chinese Journal of Dermatovenereology, 30(9):908-910.
 
Mahajan, S., Tilak, R., Kaushal, S. K., Mishra, R. N., & Pandey, S. S. (2017). Clinico-mycological study of dermatophytic infections and their sensitivity to antifungal drugs in a tertiary care center. Indian Journal of Dermatology, Venereology and Leprology, 83(4), 436-440.
Crossref
 
Nadalo, D., Montoya, C., & Hunter Smith, D. (2006). What is the best way to treat tinea cruris? The Journal of Family Practice, 55(3), 256 258.
 
Narain, U., Bajaj, A. K., & Kant, A. (2018). Tinea: Incidence during Magh Mela. International Journal of Advances in Medicine, 5(4), 993-996.
Crossref
 
Panagiotidou, D., Kousidou, T., Chaidemenos, G., Karakatsanis, G., Kalogeropoulou, A., Teknetzis, A., Chatzopoulou, E., & Michailidis, D. (1992). A Comparison of Itraconazole and Griseofulvin in the Treatment of Tinea Corporis and Tinea Cruris: A Double-Blind Study. Journal of International Medical Research, 20(5), 392-400.
Crossref
 
Patel, G. A., Wiederkehr, M., & Schwartz, R. A. (2009). Tinea cruris in children. Pediatric Dermatology, 84, 133-137.
 
Pathania, S., Rudramurthy, S. M., Narang, T., Saikia, U. N., & Dogra, S. (2018). A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India. Indian Journal of Dermatology, Venereology and Leprology, 84(6), 678-684.
Crossref
 
Paudel, D., & Manandhar, S. (2015). Dermatophytic Infections among the patients attending Di Skin Hospital and Research Center at Maharajgunj Kathmandu. Journal of Nepal Health Research Council, 13(31), 226-232.
 
Putta, S. D., Kulkarni, V. A., Bhadade, A. A., Kulkarni, V. N., & Walawalkar, A. S. (2016). Prevalence of dermatophytosis and its spectrum in a tertiary care hospital, Kolhapur. Indian Journal of Basic and Applied Medical Research, 5(3), 595-600.
 
Rotta, I., Ziegelmann, P. K., Otuki, M. F., Riveros, B. S., Bernardo, N. L., & Correr, C. J. (2013). Efficacy of topical antifungals in the treatment of dermatophytosis: a mixed-treatment comparison meta-analysis involving 14 treatments. JAMA Dermatology, 149(3), 341-349.
Crossref
 
Sabtharishi, V., Katragadda, R., & Ravinder, T. (2017). A study on the antifungal susceptibility pattern of dermatophytes isolated in a tertiary care hospital. International Journal Bioassays, 6, 5379-82.
Crossref
 
Sahai, S., & Mishra, D. (2011). Change in spectrum of dermatophytes isolated from superficial mycoses cases: First report from Central India. Indian Journal of Dermatology, Venereology and Leprology, 77(3), 335-336.
Crossref
 
Sahin, I., Oksuz, S., Kaya, D., Sencan, I., & Çetinkaya, R. (2004). Dermatophytes in the rural area of Duzce, Turkey. Mycoses, 47(11‐12), 470-474.
Crossref
 
Sahoo, A. K., & Mahajan, R. (2016). Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review. Indian Dermatology Online Journal, 7(2), 77-86.
Crossref
 
Seebacher, C., Bouchara, J. P., & Mignon, B. (2008). Updates on the epidemiology of dermatophyte infections. Mycopathologia, 166, 335-352.
Crossref
 
Shujat, U., Ikram, A., Abbasi, S. A., Ayyub, M., Mirza, I. A., & Fayyaz, M. (2014). Spectrum of superficial and deep fungal isolates in Northern Pakistan. Virology and Mycology, 3(2), 131.
Crossref
 
Sinha, A., & Kling, S. (2009). A review of adolescent obesity: prevalence, etiology, and treatment. Obesity Surgery, 19, 113-120.
Crossref
 
Xiong, Y., Zhou, C., Li, Q., Huang, X. Y., Huang, Y. H., Zhong, B. Y., Tang, S. Q., Dai, W., & Hao, F. (2008). Etiologic analysis of 2135 cases of superficial mycosis in Chongqing region. Journal of Clinical Dermatology, 37(11), 711-713.
 
Xu, W., & Li, Y. (2010). Clinical analysis of 818 cases of superficial mycosis. Guide China Medicine, 8(13), 131-132.
 
Yang, C. Y., Lin, T. L., Tzung, T. Y., Cheng, L. C., Wang, J. T., & Jee, S. H. (2007). Direct identification of dermatophyte DNA from clinical specimens by a nested polymerase chain reaction assay. Archives of Dermatology, 143(6), 799-816.
Crossref
 
Zeng, X., Zhang, Y., Kwong, J. S., Zhang, C., Li, S., Sun, F., Niu, Y., & Du, L. (2015). The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review. Journal of Evidence-Based Medicine, 8(1), 2-10.
Crossref